ArticleBMC pediatrics2025
Small fiber neuropathy in pediatric female heterozygotes of Fabry disease: a twin case report.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFabry disease, an X-linked lysosomal storage disorder, is associated with significant multisystem involvement, including small fiber neuropathy. While neuropathic pain is well-documented in females with Fabry disease, the objective confirmation of small fiber dysfunction in pediatric heterozygotes remains underreported. This study highlights the role of quantitative sensory testing (QST) in diagnosing small fiber neuropathy in young female patients. CASE REPORT: We present twin sisters, heterozygous for a pathogenic GLA variant (c.298 A > T), who exhibited symptoms of small fiber neuropathy, including acroparesthesia and gastrointestinal dysfunction. QST revealed altered thermoalgesic and vibratory thresholds in one twin and isolated vibratory hyposensitivity in the other, supporting the diagnosis of small fiber neuropathy. DISCUSSION: These cases highlight the diagnostic challenge of Fabry disease, as neuropathic symptoms may be overlooked or attributed to other conditions in pediatric patients. The findings emphasize the need for early identification of small fiber dysfunction in heterozygous females, who are increasingly recognized as being clinically affected. The complex alterations in sensory processing reinforce the importance of integrating QST as an objective assessment tool for small fiber function in Fabry disease.
conclusionsSmall fiber neuropathy is an early and clinically relevant manifestation of Fabry disease in pediatric heterozygotes. Early recognition and intervention, including enzyme replacement therapy (ERT), are essential to mitigating disease progression and improving clinical outcomes. These cases underscore the utility of QST in confirming small fiber neuropathy and highlight its potential role in the early diagnosis and monitoring of Fabry-related neuropathy in pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.